Effect of Bevacizumab Nasal Spray on Epistaxis Duration in Hereditary Hemorrhagic Telangectasia
- 6 September 2016
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA
- Vol. 316 (9) , 934-942
Abstract
This randomized trial investigates the efficacy of 3 different doses of bevacizumab nasal spray for reducing epistaxis duration in patients with hereditary hemoKeywords
This publication has 1 reference indexed in Scilit: